Your session is about to expire
← Back to Search
Continuous Glucose Monitoring for Hyperglycemia in Critical Illness
Study Summary
This trial will compare two methods of glucose monitoring in ICU patients with diabetes or hyperglycemia to see which one keeps blood glucose in target range most.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I developed high blood sugar in the ICU and I don't have diabetes.You are using continuous glucose monitors outside the hospital.You have any health reasons that make it unsafe for you to use CGMs, based on the instructions from the manufacturer.I take more than 1,000mg of acetaminophen every 6 hours.I have diabetes or have had a blood sugar level of 180 while on insulin.I am not on medications that affect CGM readings.I will need to lie face down for treatment while on insulin.Your blood sugar level is higher than the maximum allowed by the continuous glucose monitor (for example, higher than 400 mg/dL).I have been diagnosed with diabetic ketoacidosis.I am not taking hydroxyurea as it may affect my test results.I must join the study within 3 days of ICU admission due to my diabetes.I am between 18 and 89 years old.I have been diagnosed with a severe form of high blood sugar.
- Group 1: Continuous Glucose Monitoring
- Group 2: Point of Care Glucose Monitoring
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this study currently open to new participants?
"Affirmative. Clinicaltrials.gov reveals that the study, which was posted on November 2nd 2022, is actively recruiting patients for participation. 300 individuals are being sought from 1 location."
Are there any qualifications for eligibility in this research protocol?
"This clinical trial is enrolling 300 adult volunteers with diabetes or showing signs of hyperglycemia. To qualify, participants must be aged 18-89 and have either a documented case of diabetes mellitus or one blood glucose test result above 180 whilst receiving insulin therapy (either subcutaneous or intravenous). Enrolment will take place within 72 hours if the patient has previously been diagnosed with diabetes, and similarly within 72 hours after developing raised glucose levels in an ICU setting for those without such history."
Is the elderly population being taken into consideration in this trial?
"To be eligible for this trial, patients must fall within the 18-89 age range. This research has a separate pool of 223 studies available to those under 18 and 1115 that are specifically targeting individuals over 65 years old."
How many participants are being included in this clinical trial?
"Indeed, the latest update posted on clinicaltrials.gov verifies that this medical trial is still actively recruiting participants. Initiated on November 2nd 2022, it seeks to recruit 300 patients from a single site."
Share this study with friends
Copy Link
Messenger